Data / Research funding / Lung
Lung: 8,215 NIH awards ($13.9B) to 871 organizations
8,215 NIH awards ($13.9B) in the NIH spending category Lung, to 871 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 8,215 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity | NIH | National Cancer Institute | 2021 to 2025 | $2,960,824,321 | August 31, 2025 | August 30, 2026 | BRISCOE, LYNN | reporter.nih.gov |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| Trans-Omics for Precision Medicine (TOPMed) Artificial Intelligence Coordinating Center (AI-CC) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $86,600,000 | September 25, 2024 | September 30, 2029 | MONTALVAN, REBECCA | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| NCI Early Career Cancer Clinical Investigator Award | NIH | National Cancer Institute | 2021 to 2025 | $65,560,307 | March 10, 1997 | November 30, 2026 | EBERT, BENJAMIN LEVINE | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $61,029,344 | September 30, 2019 | March 31, 2027 | URDAHL, KEVIN | reporter.nih.gov |
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $39,144,749 | September 1, 1998 | August 31, 2027 | PARK, BEN HO | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $38,435,039 | September 30, 2019 | September 29, 2026 | FORTUNE, SARAH | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $35,184,139 | August 1, 2021 | July 31, 2026 | COLER, RHEA | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,858,092 | April 12, 2021 | March 31, 2028 | JACKSON, DANIEL J | reporter.nih.gov |
| Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $33,014,143 | September 25, 2023 | April 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| Neonatal Research Network Data Coordinating Center (DCC) 2023-2028 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $29,678,342 | September 1, 2025 | March 31, 2026 | DAS, ABHIK | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,642,385 | September 12, 1997 | November 30, 2025 | RATHMELL, WENDY KIMRYN | reporter.nih.gov |
| COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3 - AUGUST 10, 2025 - AUGUST 9, 2026 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $29,553,568 | August 10, 2025 | August 9, 2026 | NEWMAN, LEE S | reporter.nih.gov |
| Mayo Clinic Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,249,641 | April 25, 1997 | August 31, 2030 | WILLMAN, CHERYL LYNN | reporter.nih.gov |
| RhoFED AA-SCCC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,163,551 | May 5, 2023 | April 30, 2028 | DAVID, GLORIA | reporter.nih.gov |
| Wisconsin Infant Study Cohort (WISC) ECHO Pediatric Follow-Up | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $26,243,281 | September 21, 2016 | May 31, 2030 | GERN, JAMES E. | reporter.nih.gov |
| Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $25,628,714 | September 20, 2021 | August 31, 2027 | DAS, ABHIK | reporter.nih.gov |
| Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,809,662 | September 24, 2021 | December 31, 2026 | ALLEN, MICHELE L | reporter.nih.gov |
| Los Angeles CRS for the MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $22,107,486 | April 15, 2019 | September 30, 2026 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| Moffitt Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $22,007,955 | February 18, 1998 | January 31, 2027 | CLEVELAND, JOHN L. | reporter.nih.gov |
| University of Pittsburgh MACS/WIHS CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,988,029 | April 1, 2019 | September 30, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| Center for Research, Health and Society | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $21,943,481 | September 24, 2021 | June 30, 2027 | CORNELL, CAROL ELLEN | reporter.nih.gov |
| UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $21,851,455 | September 1, 2025 | August 31, 2026 | SCHULICK, RICHARD D | reporter.nih.gov |
| The ECHO Measurement Core: A Framework and Resource for Assessing Environmental Exposure and Child Health | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $21,486,838 | September 21, 2016 | May 31, 2030 | CELLA, DAVID | reporter.nih.gov |
| RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $21,300,494 | May 15, 2019 | April 30, 2026 | RAMACHANDRAN, VASAN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $20,980,807 | December 1, 1996 | February 28, 2029 | MAITRA, ANIRBAN | reporter.nih.gov |
| West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,261,619 | September 30, 2001 | July 31, 2029 | JOSHI, TRUPTI | reporter.nih.gov |
| Vaccine and Treatment Evaluation Units (VTEU) 24-0003 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,949,752 | December 11, 2019 | November 30, 2026 | EL SAHLY, HANA M | reporter.nih.gov |
| Louisiana Biomedical Research Network | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $18,867,890 | September 25, 2001 | April 30, 2030 | KOUSOULAS, KONSTANTIN G | reporter.nih.gov |
| The American Lung Association (ALA) Lung Health Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $17,159,433 | June 15, 2019 | June 30, 2026 | KALHAN, RAVI | reporter.nih.gov |
| International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,840,939 | May 1, 2025 | April 30, 2027 | ROHNER, ELIANE | reporter.nih.gov |
| Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $16,153,090 | May 1, 2023 | April 30, 2029 | SELF, WESLEY H | reporter.nih.gov |
| Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,828,159 | May 13, 2021 | April 30, 2027 | RHEE, KYU Y | reporter.nih.gov |
| C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $15,575,398 | July 1, 2024 | May 31, 2026 | NAHID, PAYAM | reporter.nih.gov |
| PERU Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,506,525 | December 1, 2024 | November 30, 2027 | SANCHEZ, JORGE LUIS | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,471,597 | September 14, 2021 | June 30, 2028 | MADSEN, JOREN C | reporter.nih.gov |
| PHRU-Setshaba Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,110,381 | December 1, 2024 | November 30, 2027 | GRAY, GLENDA E | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)- COORDINATING CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $15,035,695 | November 30, 2018 | November 29, 2024 | CAI, JIANWEN | reporter.nih.gov |
| Prenatal and Early Childhood Pathways To Health: An Integrated Model of Chemical and Social Exposures, Biological Mechanisms, and Sex-Specific Effects on Neurodevelopment and Respiratory Outcomes | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $14,672,582 | September 21, 2016 | August 31, 2025 | KARR, CATHERINE J | reporter.nih.gov |
| The Tisch Cancer Institute - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,629,412 | August 1, 2015 | July 31, 2030 | PARSONS, RAMON E | reporter.nih.gov |
| Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $14,399,999 | March 26, 2024 | February 28, 2029 | SAVIC, RADOJKA | reporter.nih.gov |
| Lung Transplant Clinical Trial Network (LT-CTN) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,392,000 | June 1, 2025 | May 31, 2028 | PALMER, SCOTT M | reporter.nih.gov |
| Kaiser Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,173,633 | December 11, 2019 | November 30, 2026 | JACKSON, LISA A | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,117,524 | April 1, 2019 | September 30, 2026 | GUSTAFSON, DEBORAH R. | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| Sleep for Stroke Management And Recovery Trial (Sleep SMART) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $13,933,376 | August 15, 2018 | April 30, 2027 | BROWN, DEVIN L | reporter.nih.gov |
| Massey Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,606,962 | December 1, 1995 | April 30, 2028 | WINN, ROBERT A. | reporter.nih.gov |
| Data, Modeling,and Coordination Center for PrecISE Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $13,407,521 | September 23, 2017 | June 30, 2025 | IVANOVA, ANASTASIA | reporter.nih.gov |
| IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody | NIH | National Institute on Drug Abuse | 2023 to 2025 | $13,125,765 | May 1, 2023 | April 30, 2027 | KALNIK, MATTHEW W | reporter.nih.gov |
| Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,991,264 | February 8, 2019 | January 31, 2027 | CHAVARRO, JORGE EDUARDO | reporter.nih.gov |
| Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,773,513 | January 17, 2018 | December 31, 2027 | WUNDERINK, RICHARD G | reporter.nih.gov |
| Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,580,221 | June 1, 2025 | May 31, 2027 | SETTE, ALESSANDRO | reporter.nih.gov |
| Environmental Exposure and Cardiometabolic Disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $12,324,355 | September 1, 2017 | June 30, 2027 | SRIVASTAVA, SANJAY | reporter.nih.gov |
| Development of an Optimized Adjuvanted TB Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,645,061 | September 30, 2021 | September 30, 2025 | EVANS, JAY | reporter.nih.gov |
| Sleep in Neurocognitive Aging and Alzheimers Research (SANAR) | NIH | National Institute on Aging | 2021 to 2025 | $11,494,462 | February 1, 2021 | January 31, 2027 | RAMOS, ALBERTO RAFAEL | reporter.nih.gov |
| Complement Mediated Remodeling in Pulmonary Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $11,355,302 | August 1, 2020 | June 30, 2026 | STENMARK, KURT R. | reporter.nih.gov |
| Lifecourse Approach to Developmental Repercussions of Environmental Agents on Metabolic and Respiratory health (LA DREAMERs) | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $11,345,691 | September 21, 2016 | August 31, 2024 | BRETON, CARRIE VAN DOREN | reporter.nih.gov |
| Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $11,172,471 | August 15, 2022 | July 31, 2027 | BOUCHER, RICHARD CHARLES | reporter.nih.gov |
| Advancing Vaccine Adjuvant Research for Tuberculosis (TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $10,964,476 | September 30, 2022 | September 29, 2027 | BRITTON, WARWICK | reporter.nih.gov |
| Administrative Supplement Request for 2025 Systems Biology for Infectious Diseases Annual Meeting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,511,156 | August 17, 2018 | May 31, 2028 | KROGAN, NEVAN J | reporter.nih.gov |
| Immunometabolic phenotypes in adult severe asthma and disease progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $10,501,030 | September 23, 2019 | June 30, 2025 | LEVY, BRUCE D | reporter.nih.gov |
| Penn-CHOP ECHO | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $10,439,338 | September 1, 2023 | May 31, 2025 | MUMFORD, SUNNI L. | reporter.nih.gov |
| POLYCYCLIC AROMATIC HYDROCARBONS: ULTRASENSITIVE DETECTION,EARLY LIFE EXPOSURES-CLINICAL OUTCOMES (PRETERM BIRTHS, CHRONICLUNG DISEASE, AND NEUROCOGNITIVE DEFICITS), PREVENTION ANDREMEDIATION | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $9,828,452 | February 28, 2020 | January 31, 2030 | MOORTHY, BHAGAVATULA | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| Center for Modeling Complex Interactons | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $9,684,540 | March 15, 2015 | June 30, 2025 | WICHMAN, HOLLY A | reporter.nih.gov |
| GHESKIO Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,655,243 | February 1, 2007 | November 30, 2027 | PAPE, JEAN WILLIAM | reporter.nih.gov |
| Lung Transplant Consortium - Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,634,917 | August 5, 2022 | July 31, 2027 | PALMER, SCOTT M | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2025 | $9,466,491 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $9,400,136 | September 1, 2020 | June 25, 2024 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| HCHS-SOL - AE FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $9,308,932 | November 30, 2018 | November 29, 2024 | KAPLAN, ROBERT | reporter.nih.gov |
| Transitions from Impaired Respiratory Health to Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $9,270,202 | August 15, 2014 | July 31, 2029 | KALHAN, RAVI | reporter.nih.gov |
| Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,218,182 | August 24, 2022 | July 31, 2027 | BARKER, BRIDGET MARIE | reporter.nih.gov |
| RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $8,923,910 | May 15, 2019 | April 30, 2025 | RAMACHANDRAN, VASAN S | reporter.nih.gov |
| LSU Superfund Research Center - Environmentally Persistent Free Radicals | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $8,832,607 | August 15, 2009 | January 31, 2026 | CORMIER, STEPHANIA A | reporter.nih.gov |
| Targeting Lung Cancer Vulnerabilities | NIH | National Cancer Institute | 2021 to 2024 | $8,708,604 | September 5, 1997 | August 31, 2025 | MINNA, JOHN D. | reporter.nih.gov |
| NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS YEAR 3 | NIH | National Heart, Lung, and Blood Institute | 2024 | $8,628,759 | August 23, 2024 | August 22, 2025 | SEVERYNSE-STEVENS, DIANA M | reporter.nih.gov |
| Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,604,388 | May 1, 2021 | April 30, 2027 | CAHILL, KATHERINE N | reporter.nih.gov |
| Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $8,481,225 | September 1, 2022 | August 31, 2027 | AMIN, RAOUF S. | reporter.nih.gov |
| Disordered Proteostasis as a Driver of Disease in the Aging Lung | NIH | National Institute on Aging | 2021 to 2024 | $8,161,610 | July 1, 2015 | March 31, 2025 | BUDINGER, GR SCOTT | reporter.nih.gov |
| Human Biomimetics for Mucosal Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,059,968 | March 15, 2015 | May 31, 2027 | ESTES, MARY KOLB | reporter.nih.gov |
| The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,039,533 | September 1, 2022 | August 31, 2026 | PRYHUBER, GLORIA S | reporter.nih.gov |
| Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $8,028,092 | August 23, 2019 | August 31, 2029 | SALOMONIS, NATHAN G. | reporter.nih.gov |
| 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,010,367 | September 16, 2020 | August 31, 2025 | BOECKH, MICHAEL J | reporter.nih.gov |
| Rutgers University CounterACT Center of Excellence | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $7,988,704 | September 15, 2006 | August 31, 2025 | LASKIN, JEFFREY D | reporter.nih.gov |
| Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,961,623 | September 30, 2020 | August 31, 2025 | SCHECHTMAN, KENNETH B. | reporter.nih.gov |
| DartCF: The Dartmouth Cystic Fibrosis Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,832,026 | July 1, 2018 | August 31, 2030 | MADDEN, DEAN R | reporter.nih.gov |
| Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,818,042 | February 2, 2021 | January 31, 2027 | CHANG, LARRY WILLIAM | reporter.nih.gov |
| Columbia Center for Children's Environmental Health in ECHO II: Impact of environmental exposures on children's health and the co-morbidity of asthma and ADHD. | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $7,746,645 | September 21, 2016 | May 31, 2025 | HERBSTMAN, JULIE BETH | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY (STUDY OF LATINOS) FIELD CENTER - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,735,388 | November 30, 2018 | November 29, 2024 | SCHNEIDERMAN, NEIL | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)- CHICAGO FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,683,049 | November 30, 2018 | November 29, 2024 | DAVIGLUS, MARTHA | reporter.nih.gov |
| Mechanisms Regulating Lung Injury and Early Lung Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,661,704 | July 1, 2023 | June 30, 2028 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| FEND for TB | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,632,771 | June 4, 2020 | May 31, 2026 | ELLNER, JERROLD J. | reporter.nih.gov |
| Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD | NIH | National Institute on Aging | 2021 to 2025 | $7,592,411 | August 15, 2021 | May 31, 2027 | UDEH-MOMOH, CHINEDU THERESA | reporter.nih.gov |
| The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $7,511,308 | September 10, 2021 | August 31, 2027 | SAMET, JEFFREY H. | reporter.nih.gov |
| Interactions Between the Microbiome, Immunity and Respiratory Health in Traditional Agrarian and Suburban children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,471,626 | February 1, 2013 | February 29, 2028 | GERN, JAMES E. | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2023 to 2024 | $7,403,993 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY (STUDY OF LATINOS (HCHS-SOL))FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,388,508 | November 30, 2018 | November 29, 2024 | TALAVERA, GREGORY | reporter.nih.gov |
| Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $7,285,275 | September 1, 2022 | August 31, 2024 | AMIN, RAOUF S. | reporter.nih.gov |
| TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,251,380 | September 1, 2021 | May 31, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III | NIH | National Heart, Lung, and Blood Institute | 2025 | $7,234,660 | July 25, 2025 | July 24, 2026 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| LOW-DOSE COMPUTED TOMOGRAPHY IMAGES AND CORRESPONDING DATA | NIH | National Cancer Institute | 2022 to 2024 | $7,205,078 | September 16, 2022 | September 15, 2025 | FERNANDEZ, ANNA | reporter.nih.gov |
| Adjuvant Development of the TLR4 Ligand BECC470s For Use in Influenza, S. aureus, and P. aeruginosa Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,143,498 | September 30, 2023 | September 29, 2028 | SORENSON, GREGORY | reporter.nih.gov |
| Developing a P4 Medicine Approach to Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,129,816 | July 1, 2023 | June 30, 2028 | PACK, ALLAN I | reporter.nih.gov |
| Coordinating center for the NCI small cell lung cancer research consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,127,674 | June 24, 2022 | May 31, 2027 | RUDIN, CHARLES M. | reporter.nih.gov |
| Long Term Follow up of the Lung Transplant Outcomes Group Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,078,569 | June 15, 2019 | May 31, 2027 | CHRISTIE, JASON D | reporter.nih.gov |
| 1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,867,462 | September 15, 2020 | December 15, 2026 | MARTINEZ, FERNANDO D | reporter.nih.gov |
| Optimizing Pain Treatment In Children On Mechanical ventilation (OPTICOM) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $6,866,353 | September 5, 2024 | August 31, 2029 | TRAUBE, CHANI | reporter.nih.gov |
| MIST Early Career Scholar Awards in Mucosal Immunology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,835,591 | July 25, 2011 | June 30, 2026 | ARTIS, DAVID | reporter.nih.gov |
| Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,819,944 | September 15, 2019 | August 31, 2025 | HORNIK, CHRISTOPH | reporter.nih.gov |
| Precision phenotyping of emphysema in the elderly: the MESA Lung Study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,794,185 | August 2, 2004 | January 31, 2027 | BARR, R GRAHAM | reporter.nih.gov |
| (1 of 2) Genetic Epidemiology of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 | $6,661,979 | September 27, 2007 | July 31, 2023 | CRAPO, JAMES D | reporter.nih.gov |
| Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD) | NIH | National Institute on Drug Abuse | 2023 to 2024 | $6,654,182 | August 15, 2023 | July 31, 2025 | GRIECO, JOSEPH | reporter.nih.gov |
| Understanding the Origins of Early COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,605,820 | May 1, 2020 | April 30, 2025 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Washington University/Siteman Cancer Center Lead Academic Site | NIH | National Cancer Institute | 2021 to 2025 | $6,572,668 | March 5, 2019 | February 28, 2026 | BARTLETT, NANCY L | reporter.nih.gov |
| Cavopulmonary Assist to Reverse the Fontan | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,543,627 | September 14, 2020 | August 31, 2025 | RODEFELD, MARK D | reporter.nih.gov |
| The Darbepoetin Kindergarten Development Study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,538,886 | September 1, 2023 | August 31, 2028 | BANN, CARLA M | reporter.nih.gov |
| Stellenbosch University Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,524,563 | April 15, 2007 | November 30, 2027 | HESSELING, ANNEKE CATHARINA | reporter.nih.gov |
| METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,434,161 | September 11, 2025 | August 31, 2029 | DARWIN, KATERINA HERAN | reporter.nih.gov |
| Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,398,428 | July 1, 2021 | June 30, 2027 | GENGENBACHER, MARTIN ALFONS | reporter.nih.gov |
| Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,355,182 | February 1, 2022 | December 31, 2027 | TANTISIRA, KELAN G | reporter.nih.gov |
| Early Origins of Chronic Lung Disease: From Birth to Age 45 Years | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,285,181 | June 1, 2016 | June 30, 2030 | MARTINEZ, FERNANDO D | reporter.nih.gov |
| Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths | NIH | National Institute on Drug Abuse | 2021 | $6,275,050 | September 30, 2019 | August 31, 2025 | GEREAU, ROBERT W | reporter.nih.gov |
| Developing Teixobactin for Respiratory Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,154,703 | March 22, 2021 | February 28, 2027 | HUGHES, DALLAS | reporter.nih.gov |
| Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,079,745 | December 15, 2021 | November 30, 2026 | WEESE-MAYER, DEBRA ELLYN | reporter.nih.gov |
| Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,050,572 | September 20, 2019 | March 31, 2027 | SPINO, CATHERINE A | reporter.nih.gov |
| The Boston Lung Cancer Survival Cohort | NIH | National Cancer Institute | 2021 to 2025 | $6,033,521 | June 1, 2017 | May 31, 2028 | CHRISTIANI, DAVID C | reporter.nih.gov |
| Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations | NIH | National Cancer Institute | 2021 to 2023 | $6,033,066 | April 15, 2018 | July 31, 2025 | RITZWOLLER, DEBRA P | reporter.nih.gov |
| EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment | NIH | National Cancer Institute | 2021 to 2025 | $6,012,718 | September 13, 2018 | August 31, 2028 | WONG, DAVID T | reporter.nih.gov |
| Multidisciplinary Training Program in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,983,432 | July 1, 1976 | June 30, 2027 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| BEdside Exclusion of Pulmonary Embolism in children without Radiation (BEEPER) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,885,415 | April 15, 2020 | March 31, 2026 | KLINE, JEFFREY A | reporter.nih.gov |
| 1/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,835,271 | September 15, 2023 | August 31, 2028 | RAO, SUNIL V | reporter.nih.gov |
| Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,833,457 | August 15, 2024 | May 31, 2031 | PUTCHA, NIRUPAMA | reporter.nih.gov |
| Multidisciplinary Training Program in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,823,861 | July 1, 1982 | June 30, 2028 | SHIMODA, LARISSA A. | reporter.nih.gov |
| Controlling and preventing Asthma progression and Severity in Kids (CASK) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $5,781,955 | July 20, 2016 | June 30, 2024 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,725,440 | August 1, 2017 | July 31, 2031 | SHAW, REUBEN | reporter.nih.gov |
| 1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,715,477 | September 23, 2019 | August 31, 2025 | LEVITT, JOSEPH ERIC | reporter.nih.gov |
| Mechanical Clocks During Fetal Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $5,658,660 | September 16, 2022 | August 31, 2027 | NELSON, CELESTE M | reporter.nih.gov |
| CCC for NHLBI Prevention and Early Treatment of Acute Lung Injury PETAL Network | NIH | National Heart, Lung, and Blood Institute | 2021 | $5,617,232 | June 17, 2014 | October 31, 2023 | THOMPSON, BOYD TAYLOR | reporter.nih.gov |
| Physical Activity in Pulmonary Arterial Hypertension (ACTiPH) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,556,139 | August 20, 2021 | May 31, 2027 | KAWUT, STEVEN M | reporter.nih.gov |
| 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,484,720 | September 20, 2021 | August 31, 2026 | KANER, ROBERT J | reporter.nih.gov |
| ASPiRE: Advancing Science & Practice in the Retail Environment | NIH | National Cancer Institute | 2021 to 2023 | $5,479,825 | September 1, 2018 | August 31, 2025 | RIBISL, KURT M. | reporter.nih.gov |
| Clinical Genetics and Screening for Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,442,199 | January 1, 2016 | November 30, 2026 | HUNNINGHAKE, GARY MATTHEW | reporter.nih.gov |
| NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care | NIH | National Cancer Institute | 2021 to 2025 | $5,422,908 | March 5, 2019 | February 28, 2026 | BURSTEIN, HAROLD JOHN | reporter.nih.gov |
| 1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,371,597 | September 1, 2021 | July 31, 2027 | BHATT, SURYA P. | reporter.nih.gov |
| 2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center | NIH | National Cancer Institute | 2021 to 2025 | $5,355,395 | September 17, 2018 | August 31, 2028 | WILKIE, DIANA J | reporter.nih.gov |
| Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $5,260,253 | September 21, 2016 | August 31, 2024 | WEISS, SCOTT T | reporter.nih.gov |
| Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,251,361 | September 1, 2021 | August 31, 2027 | BONAFIDE, CHRISTOPHER PETER | reporter.nih.gov |
| Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery | NIH | National Cancer Institute | 2021 to 2025 | $5,246,301 | August 1, 2015 | July 31, 2028 | MEYERSON, MATTHEW L. | reporter.nih.gov |
| Mechanistic clinical trial of blocking the IL-4/13 axis in asthmatics precision phenotyped in an aeroallergen challenge chamber before, during and after receipt of dupilumab | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,232,798 | August 18, 2022 | May 31, 2027 | AHUJA, SUNIL K | reporter.nih.gov |
| Vitamin C to Decrease Effects of Smoking during Pregnancy on Offspring Airway Function, Airway Size, and Epigenetic Correlates: VCSIP cohort follow-up through 10 Years of Age | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,223,986 | August 15, 2023 | May 31, 2028 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Novel therapeutic development for small cell lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,214,420 | August 10, 2021 | July 31, 2028 | RUDIN, CHARLES M. | reporter.nih.gov |
| Chromosome Instability Drives Metal-Induced Lung Cancer | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $5,203,730 | August 1, 2021 | June 30, 2029 | WISE, JOHN PIERCE | reporter.nih.gov |
| Continued follow-up of the Vitamin C and Smoking in Pregnancy (VCSIP) cohorts through the ECHO consortium, focus on Echo-wide protocols, respiratory outcomes, airway function, and epigenetic changes | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $5,158,536 | September 21, 2016 | May 31, 2030 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimer’s disease risk in older Blacks/African-Americans | NIH | National Institute on Aging | 2023 to 2025 | $5,141,003 | June 1, 2023 | April 30, 2028 | BUBU, OMONIGHO A MICHAEL | reporter.nih.gov |
| Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,089,144 | August 16, 2010 | August 31, 2027 | GROGAN, ERIC L | reporter.nih.gov |
| Adaptable tissue-specific endothelial cells for organ regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,071,342 | April 1, 2020 | March 31, 2027 | RAFII, SHAHIN | reporter.nih.gov |
| Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,061,587 | May 10, 2021 | April 30, 2027 | TRAPNELL, BRUCE C | reporter.nih.gov |
| BioRepository for INvestigation of Diseases of the Lung (BRINDL) - Phase III | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,051,640 | August 23, 2019 | August 31, 2029 | PRYHUBER, GLORIA S | reporter.nih.gov |
| Novel vascular smooth muscle cell progenitors in development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,999,830 | July 1, 2020 | June 30, 2027 | GREIF, DANIEL | reporter.nih.gov |
| Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis | NIH | National Cancer Institute | 2021 to 2025 | $4,951,939 | August 14, 2015 | July 31, 2029 | ATTARDI, LAURA D | reporter.nih.gov |
| Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $4,927,507 | May 5, 2010 | August 31, 2025 | VANDENBORNE, KRISTA H | reporter.nih.gov |
| Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,919,940 | April 15, 2019 | June 30, 2026 | ERLE, DAVID J | reporter.nih.gov |
| Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults | NIH | National Institute on Aging | 2021 to 2025 | $4,900,406 | April 1, 2021 | March 31, 2027 | VANDERHORST, VERONIQUE | reporter.nih.gov |
| Clinical Validation Center for Lung Cancer Early Detection | NIH | National Cancer Institute | 2022 to 2025 | $4,880,009 | September 1, 2022 | August 31, 2027 | HANASH, SAMIR M | reporter.nih.gov |
| Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure and Health Outcomes | NIH | National Cancer Institute | 2021 to 2023 | $4,874,420 | December 15, 2017 | November 30, 2023 | THORPE, LORNA | reporter.nih.gov |
| ASSESSING THE EVOLVING IMPACT OF EARLY LIFE EXPOSURES ON CHILD PHYSICAL HEALTH AND NEURODEVELOPMENT | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $4,873,931 | September 21, 2016 | May 31, 2025 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,842,777 | April 1, 2022 | March 31, 2027 | KOTH, LAURA L | reporter.nih.gov |
| Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,831,256 | December 1, 2021 | November 30, 2026 | RENGARAJAN, JYOTHI | reporter.nih.gov |
| Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $4,829,392 | July 15, 2013 | July 31, 2025 | PANETTIERI, REYNOLD ALEXANDER | reporter.nih.gov |
| Program to promote lung regeneration and block fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,819,926 | February 15, 2020 | February 14, 2026 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,799,861 | September 15, 2020 | August 31, 2025 | DIAMOND, MICHAEL S | reporter.nih.gov |
| Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,760,584 | September 23, 2025 | August 31, 2030 | NAHID, PAYAM | reporter.nih.gov |
| Organizational strategies for improving evidence-uptake in intensive care | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,750,730 | January 21, 2019 | February 28, 2026 | KAHN, JEREMY M | reporter.nih.gov |
| TIDES III: Endocrine Disruption, Hormones, and Sex Differences in Adolescent Airway Health | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $4,747,443 | May 1, 2015 | May 31, 2027 | SATHYANARAYANA, SHEELA | reporter.nih.gov |
| Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies | NIH | National Cancer Institute | 2021 to 2025 | $4,726,654 | September 9, 2019 | August 31, 2026 | SAGE, JULIEN | reporter.nih.gov |
| PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,716,636 | May 1, 2025 | April 30, 2027 | KOENIG, SERENA PATRICIA | reporter.nih.gov |
| Transplanting Lungs from Uncontrolled Donation after Circulatory Death | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $4,714,267 | July 8, 2022 | June 30, 2027 | WALL, STEPHEN P | reporter.nih.gov |
| Defining and Controlling Airway Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,706,100 | March 8, 2019 | February 28, 2026 | HOLTZMAN, MICHAEL J | reporter.nih.gov |
| Human metabolic variation as a window into cancer initiation and progression | NIH | National Cancer Institute | 2021 to 2025 | $4,687,860 | September 4, 2017 | August 31, 2030 | DEBERARDINIS, RALPH J | reporter.nih.gov |
| Noninvasive measurement of oxygenation using quantitative susceptibility mapping | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,679,068 | January 1, 2021 | December 31, 2026 | SPINCEMAILLE, PASCAL | reporter.nih.gov |
| Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions | NIH | National Cancer Institute | 2022 to 2025 | $4,678,848 | December 3, 2022 | August 31, 2026 | MEZA, RAFAEL | reporter.nih.gov |
| Neurobiology of the Bronchopulmonary System | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,659,693 | March 1, 2021 | February 28, 2028 | UNDEM, BRADLEY JOEL | reporter.nih.gov |
| Multi-Disciplinary Research Training in Respiratory Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,648,798 | July 1, 1975 | June 30, 2030 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,646,035 | March 25, 2019 | February 28, 2026 | PETERS-GOLDEN, MARC L | reporter.nih.gov |
| Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,644,868 | September 1, 2021 | August 31, 2027 | GRISSOM, COLIN KERST | reporter.nih.gov |
| Developmental Impact of NICU Exposures (DINE) | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $4,609,720 | September 21, 2016 | August 31, 2025 | ASCHNER, JUDY LYNN | reporter.nih.gov |
| Monitoring of disease-induced skin VOC patterns from handheld and wearable chemical sensors | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,608,903 | June 22, 2022 | May 31, 2027 | DAVIS, CRISTINA ELIZABETH | reporter.nih.gov |
| Common and distinct early environmental influences on cardiometabolic and respiratory health: Mechanisms and methods | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $4,549,129 | September 21, 2016 | August 31, 2024 | OKEN, EMILY | reporter.nih.gov |
| DEVELOPMENT, MAINTENANCE, AND PROMOTION OF NCI SPONSORED BEHAVIORAL AND MOBILE HEALTH INITIATIVES. | NIH | National Cancer Institute | 2021 to 2024 | $4,522,410 | September 15, 2021 | September 14, 2025 | SCHWARZ, MARY | reporter.nih.gov |
| Controlling and Preventing Asthma Progression and Severity in Kids with Omalizumab Extension (PARK-EXT) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $4,500,000 | July 8, 2024 | April 30, 2029 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| Effect of IL-4RαR576 variant on response to Dupilumab in children with Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,492,892 | April 11, 2019 | March 31, 2026 | PHIPATANAKUL, WANDA | reporter.nih.gov |
| Impact of tuberculosis on the development and function of the immune system in SIV-infected infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $4,476,086 | April 1, 2019 | March 31, 2025 | WANG, XIAOLEI | reporter.nih.gov |
| Early Pathogenesis of Cystic Fibrosis Related Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,452,977 | April 30, 2021 | March 31, 2024 | ENGELHARDT, JOHN F | reporter.nih.gov |
| Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer Care | NIH | National Cancer Institute | 2021 to 2025 | $4,423,867 | August 1, 2015 | August 31, 2029 | FIORE, MICHAEL C | reporter.nih.gov |
| Cell-cell interactions governing lung epithelial progenitor cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,407,300 | March 15, 2020 | January 31, 2027 | KIM, CARLA F. | reporter.nih.gov |
| Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,398,832 | April 7, 2020 | March 31, 2027 | RANDALL, TROY D | reporter.nih.gov |
| New Approaches for Empowering Studies of Asthma in Populations of African Descent | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,384,624 | September 28, 2011 | November 30, 2023 | BARNES, KATHLEEN C | reporter.nih.gov |
| Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,382,400 | March 5, 2019 | February 28, 2026 | EVANS, SCOTT E. | reporter.nih.gov |
| 1/2 PROSpect: Prone and Oscillation Pediatric Clinical Trial (CCC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,351,796 | June 15, 2018 | July 31, 2025 | CURLEY, MARTHA AQ | reporter.nih.gov |
| High performance wearable body odor sensor arrays for disease detection and monitoring | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,350,648 | August 10, 2022 | May 31, 2027 | FAN, XUDONG | reporter.nih.gov |
| ASSESSING THE EVOLVING IMPACT OF EARLY LIFE EXPOSURES ON CHILD PHYSICAL HEALTH AND NEURODEVELOPMENT | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $4,337,861 | September 21, 2016 | May 31, 2030 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $4,320,983 | August 20, 2020 | July 31, 2025 | MCCORMACK, MEREDITH C | reporter.nih.gov |
| The Maximizing Extubation outcomes Through Educational and Organizational Research (METEOR) Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,315,155 | September 1, 2021 | August 31, 2026 | GIRARD, TIMOTHY D | reporter.nih.gov |
| Preclinical Pulmonary Fibrosis, an opportune rare disease cohort | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,290,758 | August 20, 2020 | July 31, 2026 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| Viral and immune-mediated CNS pathology during SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,269,302 | July 24, 2020 | June 30, 2025 | IWASAKI, AKIKO | reporter.nih.gov |
| Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,258,583 | August 20, 2020 | June 30, 2026 | D'ARMIENTO, JEANINE M | reporter.nih.gov |
| Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,252,869 | July 1, 2018 | February 28, 2027 | GELFAND, CRAIG | reporter.nih.gov |
| Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,248,593 | July 1, 2025 | June 30, 2027 | AULD, SARA | reporter.nih.gov |
| Preventing TB with intravenous BCG in SIV-infected macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,248,442 | May 5, 2021 | April 30, 2026 | SCANGA, CHARLES A. | reporter.nih.gov |
| Influenza pathogenesis in pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,248,239 | June 14, 2021 | May 31, 2027 | ADAMS WALDORF, KRISTINA M. | reporter.nih.gov |
| Combined Cardiopulmonary Failure in COPD: SPIROMICS HF | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $4,223,234 | August 28, 2008 | June 30, 2025 | BARR, R GRAHAM | reporter.nih.gov |
| Molecular Regulation of Progressive Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,220,741 | March 1, 2020 | February 28, 2027 | NOBLE, PAUL WESLEY | reporter.nih.gov |
| The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,208,331 | June 1, 2020 | July 31, 2030 | SESHADRI, CHETAN | reporter.nih.gov |
| Influence of NT5c1A antibodies on disease progression, clinical phenotype and blood and muscle biomarkers in sporadic Inclusion Body Myositis - A prospective evaluation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $4,186,266 | April 1, 2021 | March 31, 2027 | MOZAFFAR, TAHSEEN | reporter.nih.gov |
| MSC Exosome Treatment for BPD: Impact on Immunity and Lung Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,182,213 | March 1, 2019 | February 28, 2027 | KOUREMBANAS, STELLA | reporter.nih.gov |
| Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $4,174,965 | April 6, 2021 | April 5, 2023 | KIL, JONATHAN | reporter.nih.gov |
| Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,161,751 | September 24, 2018 | July 31, 2025 | SHEPPARD, DEAN | reporter.nih.gov |
| Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,152,012 | February 1, 2023 | January 31, 2027 | KHADER, SHABAANA A. | reporter.nih.gov |
| Investigating the Roles of Patient Beliefs, and Physician Communication on Disparities in Lung Cancer Screening | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $4,149,463 | September 20, 2021 | May 31, 2027 | KALE, MINAL S | reporter.nih.gov |
| Novel Therapeutics for Opioid Use Disorder in the Acute Overdose and Maintenance Settings | NIH | National Institute on Drug Abuse | 2022 to 2023 | $4,143,992 | September 30, 2019 | August 31, 2025 | GEHLERT, DONALD R | reporter.nih.gov |
| Development of mRNA-platform vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,121,318 | January 21, 2021 | December 31, 2026 | DAMRON, FREDRICK HEATH | reporter.nih.gov |
| Multidisciplinary Training Program in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,120,916 | July 1, 1993 | June 30, 2028 | DICKSON, ROBERT PICKETT | reporter.nih.gov |
| Impact of Sleep Duration on Immune Balance in Urban Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,100,188 | August 15, 2021 | July 31, 2026 | KOINIS MITCHELL, DAPHNE | reporter.nih.gov |
| Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance | NIH | National Cancer Institute | 2021 to 2024 | $4,095,825 | September 10, 2018 | August 31, 2025 | JANNE, PASI A | reporter.nih.gov |
| A STINGing vaccine for TB | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,090,805 | June 1, 2020 | May 31, 2026 | BISHAI, WILLIAM RAMSES | reporter.nih.gov |
| PET-MR Imaging of pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,079,636 | July 1, 2021 | June 30, 2026 | CARAVAN, PETER D | reporter.nih.gov |
| Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,065,243 | March 15, 2021 | February 28, 2027 | DEBAUN, MICHAEL R. | reporter.nih.gov |
| Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $4,042,959 | January 25, 2023 | December 31, 2027 | LOUIE, ARNOLD | reporter.nih.gov |
| Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,976,850 | August 15, 2024 | July 31, 2028 | HAMVAS, AARON | reporter.nih.gov |
| Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,964,079 | January 1, 2022 | December 31, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| OMEGA COPD Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,929,943 | September 20, 2021 | August 31, 2027 | HANSEL, NADIA N | reporter.nih.gov |
| Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $3,928,528 | July 22, 2016 | August 31, 2028 | HEINE, JOHN J | reporter.nih.gov |
| Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,920,220 | June 13, 2022 | May 31, 2027 | GOVINDAN, RAMASWAMY | reporter.nih.gov |
| Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,919,631 | February 3, 2021 | January 31, 2027 | CLEVELAND, ZACKARY I | reporter.nih.gov |
| Omic Determinants of Longitudinal Lung Function in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,917,165 | June 1, 2021 | May 31, 2027 | MCGEACHIE, MICHAEL JOHN | reporter.nih.gov |
| Bringing 4π radiation therapy to the clinic | NIH | National Cancer Institute | 2022 to 2024 | $3,911,244 | May 6, 2022 | April 30, 2025 | YONEMOTO, JAY | reporter.nih.gov |
| ECHO II: Impact of environmental exposures on children's health and the co-morbidity of asthma and ADHD | NIH | Office of the Director, National Institutes of Health | 2025 | $3,884,884 | September 21, 2016 | May 31, 2030 | MILLER, RACHEL L | reporter.nih.gov |
| Bay Area Cancer Target Discovery and Development | NIH | National Cancer Institute | 2022 to 2025 | $3,880,946 | September 13, 2022 | August 31, 2027 | MCMANUS, MICHAEL T | reporter.nih.gov |
| Investigating Individual Susceptibility and Host Response in Acute Respiratory Distress Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,880,499 | August 19, 2022 | July 31, 2029 | MEYER, NUALA JENNINGS | reporter.nih.gov |
| Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,876,556 | March 15, 2021 | February 28, 2027 | HORWITZ, MARCUS AARON | reporter.nih.gov |
| Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,866,357 | September 17, 2021 | August 31, 2027 | STEINBACH, WILLIAM J | reporter.nih.gov |
| Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium Infection | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $3,863,432 | September 19, 2022 | July 31, 2027 | WINTHROP, KEVIN LORING | reporter.nih.gov |
| Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,862,565 | February 1, 2023 | January 31, 2028 | FLORIN, TODD ADAM | reporter.nih.gov |
| Cellular and molecular programming of lung resident T cell memory | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,857,630 | May 1, 2020 | April 30, 2027 | KOHLMEIER, JACOB E | reporter.nih.gov |
| Precision Medicine in the Acute Respiratory Distress Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,851,458 | January 16, 2018 | March 31, 2025 | CALFEE, CAROLYN | reporter.nih.gov |
| An automated portable system for detecting and treating opioid induced respiratory depression | NIH | National Institute on Drug Abuse | 2022 to 2024 | $3,830,637 | April 1, 2022 | February 28, 2026 | MACKIE, KENNETH | reporter.nih.gov |
| Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards | NIH | National Cancer Institute | 2021 to 2022 | $3,820,230 | September 20, 2017 | August 31, 2024 | HATSUKAMI, DOROTHY K | reporter.nih.gov |
| Advanced Genotypic and Phenotypic monitoring of Drug Resistant TB to Improve TB Treatment Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,809,183 | August 1, 2015 | July 31, 2030 | LARSEN, MICHELLE H | reporter.nih.gov |
| Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,805,993 | June 1, 2021 | May 31, 2027 | LIAO, ZHONGXING | reporter.nih.gov |
| Dissecting the Interoception Circuit that Controls Airway Constriction | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,805,305 | September 1, 2021 | August 31, 2026 | SUN, XIN | reporter.nih.gov |
| Sleep and health disparities among Asian Americans: roles of stressors and protective factors | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,796,997 | April 8, 2021 | January 31, 2027 | LEE, SUNMIN | reporter.nih.gov |
| Cell competition in pulmonary fibrosis and ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,796,920 | August 20, 2022 | July 31, 2029 | DE LANGHE, STIJN PIET JOHAN | reporter.nih.gov |
| Lung Macrophage Programming in Acute Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,783,173 | February 15, 2018 | January 31, 2026 | JANSSEN, WILLIAM | reporter.nih.gov |
| Electronic Pediatric Office Systems to Support Treatment for Parental Tobacco Use | NIH | National Cancer Institute | 2021 to 2024 | $3,780,101 | January 1, 2020 | December 31, 2025 | WINICKOFF, JONATHAN P | reporter.nih.gov |
| Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy | NIH | National Cancer Institute | 2021 to 2024 | $3,779,781 | August 15, 2018 | July 31, 2025 | GRANDIS, JENNIFER RUBIN | reporter.nih.gov |
| Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,775,343 | January 1, 2019 | April 30, 2028 | BANOVICH, NICHOLAS ELI | reporter.nih.gov |
| Genetic Investigation of Covid 19 in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,774,284 | August 1, 2022 | July 31, 2027 | KAHN, MARK L | reporter.nih.gov |
| Columbus NCORP RFA-CA-18-016 | NIH | National Cancer Institute | 2021 to 2025 | $3,771,688 | August 1, 2014 | July 31, 2026 | RAJAGOPALAN, MALOLAN S | reporter.nih.gov |
| Genetic Epidemiology of Sleep Apnea and Comorbidities in Biobanks | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,744,652 | August 16, 2021 | July 31, 2027 | CADE, BRIAN EDMAND | reporter.nih.gov |
| Molecular Imaging CCR2 Lung Inflammation and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,741,003 | February 5, 2021 | December 31, 2026 | BRODY, STEVEN | reporter.nih.gov |
| Systematic Investigation of Protein Ubiquitination in ARDS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,737,220 | January 26, 2018 | November 30, 2025 | CHEN, BEIBEI | reporter.nih.gov |
| Epidural spinal cord stimulation and respiratory motor function after injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,733,906 | May 1, 2021 | February 28, 2027 | OVECHKIN, ALEXANDER VLADIMIROVICH | reporter.nih.gov |
| Understanding Oral Diseases in Cystic Fibrosis to Develop Tailored Preventive Dental Interventions | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,727,321 | April 13, 2021 | March 31, 2027 | KIM, AMY S | reporter.nih.gov |
| Estimating the risk for and severity of respiratory infections attributable to CFTR heterozygosity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,719,716 | April 1, 2021 | March 31, 2027 | POLGREEN, PHILIP M | reporter.nih.gov |
| Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,714,524 | September 30, 2025 | September 29, 2026 | ESSER-KAHN, AARON | reporter.nih.gov |
| Inborn errors of immunity in patients with life-threatening COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,707,765 | July 12, 2021 | June 30, 2026 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| THE ROLE OF THE NON-CANONICAL INFLAMMASOME IN INNATE IMMUNITY | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,707,189 | June 11, 2021 | May 31, 2027 | AMER, AMAL O | reporter.nih.gov |
| Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,703,807 | September 1, 2021 | August 31, 2026 | NEZAFAT, REZA | reporter.nih.gov |
| Stimulation of novel spinal respiratory circuit to restore breathing in ventilator-dependent patients with SCI. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,702,825 | August 1, 2021 | December 31, 2027 | LU, DANIEL | reporter.nih.gov |
| Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,694,016 | March 4, 2021 | February 28, 2027 | MAGEE, MATTHEW JAMES | reporter.nih.gov |
| Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,693,137 | May 1, 2021 | March 31, 2027 | LYON, CHRISTOPHER J | reporter.nih.gov |
| Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,692,582 | September 27, 2021 | June 30, 2027 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| Inflammation and thrombosis fuel cardiovascular and pulmonary disease: Focus on the interplay of neutrophil inflammasomes with NETs | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,692,220 | March 15, 2023 | February 28, 2030 | WAGNER, DENISA D | reporter.nih.gov |
| Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,689,933 | July 15, 2021 | June 30, 2026 | OZ, GULIN | reporter.nih.gov |
| Case-Control Study of Methamphetamine in Pulmonary Arterial Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,677,031 | August 20, 2021 | May 31, 2027 | KAWUT, STEVEN M | reporter.nih.gov |
| Look inward: brainstem and cortical circuits for boosting interoceptive attention | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $3,675,000 | September 30, 2019 | July 31, 2025 | ANDERMANN, MARK L | reporter.nih.gov |
| Tissue-engineered trachea composites for long-segment airway replacement | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,672,010 | July 16, 2021 | June 30, 2027 | CHIANG, TENDY | reporter.nih.gov |
| 2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,669,568 | September 17, 2021 | August 31, 2026 | SPINO, CATHERINE A | reporter.nih.gov |
| Studying factors controlling cancer progression and immune recognition in mouse models | NIH | National Cancer Institute | 2022 to 2025 | $3,664,660 | September 20, 2022 | August 31, 2029 | JACKS, TYLER E. | reporter.nih.gov |
| Advancing the development of a novel class of small molecules for treating pan-coronavirus infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,659,295 | August 10, 2021 | July 31, 2027 | EINAV, SHIRIT | reporter.nih.gov |
| The Bring BPaL2Me Trial - Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,655,506 | March 10, 2023 | February 29, 2028 | FARLEY, JASON EDWARD | reporter.nih.gov |
| Emulating Immune Dysregulation by Trisomy 21 in a Multi-Organ-on-a-Chip System | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,649,414 | September 20, 2021 | July 31, 2026 | HAJIPOURAN BENAM, KAMBEZ | reporter.nih.gov |
| Programming of PMN host-defense function during transendothelial migration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,648,697 | June 11, 1993 | June 30, 2027 | KOMAROVA, YULIA A | reporter.nih.gov |
| Lymphatics-Glymphatics in CNS Fluid Homeostasis | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,644,017 | April 1, 2021 | March 31, 2026 | BENVENISTE, HELENE D | reporter.nih.gov |
| Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,610,454 | August 5, 2021 | July 31, 2025 | RENGARAJAN, JYOTHI | reporter.nih.gov |
| Fusion inhibitors that block host-to-host transmission of SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,603,355 | August 1, 2021 | July 31, 2027 | POROTTO, MATTEO | reporter.nih.gov |
| Development of ureadepsipetides for drug-resistant infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,597,406 | December 17, 2018 | November 30, 2024 | LAFLEUR, MICHAEL | reporter.nih.gov |
| Empathic Communication Skills Training to Reduce Lung Cancer Stigma | NIH | National Cancer Institute | 2021 to 2025 | $3,592,601 | September 9, 2021 | August 31, 2027 | BANERJEE, SMITA | reporter.nih.gov |
| SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression | NIH | National Heart, Lung, and Blood Institute | 2021 | $3,589,191 | September 15, 2017 | November 30, 2024 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism | NIH | National Cancer Institute | 2021 to 2025 | $3,588,137 | September 22, 2021 | August 31, 2027 | DENKO, NICHOLAS C. | reporter.nih.gov |
| Towards personalized medicine: pathophysiologic contributions to post-stroke sleep apnea | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,584,181 | April 10, 2023 | February 28, 2027 | BROWN, DEVIN L | reporter.nih.gov |
| Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,578,239 | February 1, 2018 | April 30, 2029 | DICK, THOMAS | reporter.nih.gov |
| Inhaled tigecycline therapy for pulmonary M. abscessus infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,573,339 | June 29, 2021 | May 31, 2027 | GONZALEZ-JUARRERO, MERCEDES | reporter.nih.gov |
| Pediatric Respiratory Illness Measurement System (PRIMES) Implementation in Community Hospital Settings | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,572,023 | September 20, 2021 | December 31, 2027 | MANGIONE-SMITH, RITA | reporter.nih.gov |
| 1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,567,710 | May 15, 2019 | August 31, 2022 | GLADWIN, MARK T | reporter.nih.gov |
| CD4_T-cell_Immunity_in_the_Lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,557,478 | February 1, 2018 | January 31, 2025 | KOLLS, JAY K | reporter.nih.gov |
| COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,552,656 | April 12, 2017 | June 30, 2027 | SILVERMAN, EDWIN K | reporter.nih.gov |
| Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $3,549,010 | July 8, 2021 | February 28, 2027 | SHARMA, SONIA | reporter.nih.gov |
| Novel mechanisms regulating immunity to respiratory virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,546,288 | August 2, 2023 | July 31, 2027 | PAUST, SILKE | reporter.nih.gov |
| The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,543,436 | March 1, 2022 | February 28, 2027 | TEIJARO, JOHN ROSS | reporter.nih.gov |
| Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,542,038 | June 1, 2020 | April 30, 2026 | DAHLIN, AMBER | reporter.nih.gov |
| Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers | NIH | National Cancer Institute | 2021 to 2024 | $3,536,890 | April 1, 2020 | September 30, 2025 | AMBINDER, RICHARD FREDERICK | reporter.nih.gov |
| Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial | NIH | National Cancer Institute | 2023 to 2025 | $3,532,837 | September 20, 2023 | August 31, 2028 | BRICKER, JONATHAN B | reporter.nih.gov |
| University of California and UT Southwestern D-PDTC | NIH | National Cancer Institute | 2023 to 2025 | $3,532,429 | August 1, 2023 | July 31, 2028 | CARVAJAL CARMONA, LUIS GUILLERMO | reporter.nih.gov |
| SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,531,329 | July 1, 1987 | July 31, 2026 | WEISS, SCOTT T | reporter.nih.gov |
| SARS-CoV-2 and Precursors of Alzheimer's Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational Cohort | NIH | National Institute on Aging | 2021 | $3,529,440 | September 1, 2021 | August 31, 2025 | SESHADRI, SUDHA | reporter.nih.gov |
| Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,527,794 | April 15, 2021 | March 31, 2027 | LANCIONI, CHRISTINA LOUISE | reporter.nih.gov |
| Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,525,766 | April 1, 2019 | March 31, 2027 | BHARAT, ANKIT | reporter.nih.gov |
| Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,521,973 | August 31, 2024 | April 30, 2027 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers | NIH | National Cancer Institute | 2021 to 2025 | $3,519,313 | July 12, 2021 | June 30, 2026 | DUCKETT, DEREK RONALD | reporter.nih.gov |
| Sleep and circadian rhythm phenotypes and mechanisms associated with opioid use disorder treatment outcomes | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,516,481 | September 30, 2023 | August 31, 2027 | HUHN, ANDREW S | reporter.nih.gov |
| Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,506,389 | June 1, 2020 | May 31, 2027 | BASTARACHE, JULIE A. | reporter.nih.gov |
| De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,504,899 | August 2, 2021 | July 31, 2026 | BAKER, DAVID | reporter.nih.gov |
| An Aging Alveolar Lung Model in Microgravity | NIH | National Center for Advancing Translational Sciences | 2025 | $3,504,482 | September 30, 2025 | August 31, 2028 | ZHANG, Y. SHRIKE | reporter.nih.gov |
| Control of Pulmonary Inflammation by Leukotriene E4 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,503,395 | August 13, 2021 | July 31, 2026 | BOYCE, JOSHUA A | reporter.nih.gov |
| THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,499,688 | July 1, 2023 | June 30, 2026 | HART, BARRY | reporter.nih.gov |
| Microglial regulation of intermittent hypoxia induced phrenic motor plasticity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,499,680 | September 23, 2025 | June 30, 2027 | MITCHELL, GORDON S. | reporter.nih.gov |
| Environmental Determinants of Sleep Disparities and the Consequences for Low Income Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,496,732 | August 15, 2021 | July 31, 2027 | MCCORMACK, MEREDITH C | reporter.nih.gov |
| Optimizing Lung Cancer Screening Nodule Evaluation | NIH | National Cancer Institute | 2021 to 2025 | $3,489,759 | August 1, 2021 | July 31, 2026 | KONG, CHUNG YIN | reporter.nih.gov |
| ECHO Renewal for the INSPIRE Study Cohort | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $3,488,939 | September 1, 2023 | May 31, 2025 | HARTERT, TINA V | reporter.nih.gov |
| Improving shared decision making in lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,484,257 | August 15, 2021 | July 31, 2027 | HART, JOANNA LEE | reporter.nih.gov |
| Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,483,730 | September 1, 2023 | August 31, 2028 | ROSEN, DAVID A. | reporter.nih.gov |
| Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,483,414 | September 10, 2020 | August 31, 2027 | CASKEY, RACHEL | reporter.nih.gov |
| Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,482,387 | February 1, 2022 | January 31, 2027 | DEBLEY, JASON S | reporter.nih.gov |
| Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,481,554 | September 1, 2021 | July 31, 2027 | KWON, YOUNGHOON | reporter.nih.gov |
| Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,479,164 | February 17, 2016 | April 30, 2027 | SURESH, MARULASIDDAPPA | reporter.nih.gov |
| Mechanisms of Alveolar Homeostasis, Injury, Regeneration, and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,471,063 | March 1, 2022 | February 28, 2029 | ZEMANS, RACHEL LYNNE | reporter.nih.gov |
| Enhancing Respiratory Motor Function after Spinal Cord Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,467,620 | January 1, 2019 | March 31, 2027 | SIECK, GARY C. | reporter.nih.gov |
| ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center | NIH | National Cancer Institute | 2021 to 2025 | $3,465,294 | January 2, 2025 | February 28, 2026 | LEAL, TICIANA | reporter.nih.gov |
| 1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,465,062 | September 10, 2023 | August 31, 2029 | HANSEL, NADIA N | reporter.nih.gov |
| Patterns of Cardiopulmonary health across the life course | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,464,936 | September 1, 2021 | May 31, 2027 | KHAN, SADIYA SANA | reporter.nih.gov |
| Host-mediated zinc sequestration during Acinetobacter baumannii infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,464,931 | January 15, 2013 | March 31, 2028 | SKAAR, ERIC P | reporter.nih.gov |
| Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity. | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,460,586 | April 1, 2023 | March 31, 2027 | KONSIN, JOHN PHILLIP | reporter.nih.gov |
| Immunobiology of Lung Injury and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,455,443 | January 21, 2019 | December 31, 2024 | MOORE, BETHANY B. | reporter.nih.gov |
| The MYC Transcription Factor Network and the Path to Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,449,610 | September 1, 2018 | August 31, 2025 | EISENMAN, ROBERT NEIL | reporter.nih.gov |
| Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,448,227 | December 10, 2020 | November 30, 2025 | NEEL, BENJAMIN G. | reporter.nih.gov |
| Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures | NIH | National Cancer Institute | 2021 to 2025 | $3,442,093 | January 1, 2021 | December 31, 2025 | MALDONADO, FABIEN | reporter.nih.gov |
| Development of SP-A Derived Peptidomimetics for the Treatment of Asthma - Phase II | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $3,433,831 | September 26, 2022 | August 31, 2025 | LEDFORD, JULIE GUNNELLS | reporter.nih.gov |
| Targeting TB transmission hotspots to find undiagnosed TB in South Africa: a genomic, geospatial and modeling study (TARGET- TB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,433,190 | May 1, 2025 | April 30, 2027 | MATHEMA, BARUN | reporter.nih.gov |
| Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity | NIH | National Cancer Institute | 2021 to 2025 | $3,431,899 | February 1, 2021 | January 31, 2026 | MERAD, MIRIAM | reporter.nih.gov |
| Metformin for chemoprevention of lung cancer in obese subjects at high risk | NIH | National Cancer Institute | 2021 to 2025 | $3,423,650 | August 1, 2021 | July 31, 2027 | YENDAMURI, SAIKRISHNA | reporter.nih.gov |
| Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations | NIH | National Cancer Institute | 2022 to 2025 | $3,421,613 | October 1, 2022 | August 31, 2027 | CARTER-BAWA, LISA | reporter.nih.gov |
| Inhibition of central CO2 chemoreception by seizures: Effects on ventilation, cardiovascular control and postictal recovery of consciousness | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,420,815 | September 15, 2019 | May 31, 2029 | RICHERSON, GEORGE B | reporter.nih.gov |
| Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,417,860 | July 8, 2021 | June 30, 2027 | DENG, MARIO C. | reporter.nih.gov |
| Optimizing Lung Cancer Screening in Cancer Survivors | NIH | National Cancer Institute | 2021 to 2025 | $3,415,788 | July 15, 2021 | June 30, 2027 | WISNIVESKY, JUAN P | reporter.nih.gov |
| Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,411,183 | August 5, 2020 | May 31, 2026 | HALTERMAN, JILL S | reporter.nih.gov |
| Viral and allergen-driven immunity in chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,410,907 | March 1, 2020 | January 31, 2027 | LUKACS, NICHOLAS W | reporter.nih.gov |
| Role of MIF and CD74 in the pathogenesis of emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,410,379 | January 1, 2021 | December 31, 2026 | BUCALA, RICHARD J | reporter.nih.gov |
| Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,410,042 | February 21, 2019 | January 31, 2025 | PERLIN, DAVID S | reporter.nih.gov |
| Metal Exposure and Subclinical Lung Disease in Adult E-cigarette Users | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,409,256 | February 15, 2021 | January 31, 2027 | OELSNER, ELIZABETH | reporter.nih.gov |
| Immunobiology of Influenza Virus-related Critical Illness in Young Hosts | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,406,427 | September 18, 2020 | August 31, 2025 | RANDOLPH, ADRIENNE G | reporter.nih.gov |
| Respiratory Sinus Arrhythmia as a Predictor of Substance Use among Early Adolescents | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,393,809 | September 1, 2021 | June 30, 2027 | HOUCK, CHRISTOPHER D. | reporter.nih.gov |
| Nasal epithelial epigenomics and transcriptomics and asthma in Hispanic adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,386,733 | June 1, 2021 | May 31, 2027 | CELEDON, JUAN CARLOS | reporter.nih.gov |
| Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,379,247 | August 1, 2019 | July 31, 2025 | GREENBERG, DAVID ELIHU | reporter.nih.gov |
| Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data | NIH | National Cancer Institute | 2021 to 2025 | $3,377,653 | January 22, 2021 | December 31, 2026 | CAI, QIUYIN | reporter.nih.gov |
| INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,376,507 | June 6, 2011 | June 30, 2026 | HOHL, TOBIAS M | reporter.nih.gov |
| Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,375,497 | February 18, 2022 | January 31, 2027 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| Inhalation Therapy Platform for Coronavirus Infection Treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,373,230 | September 17, 2021 | August 31, 2026 | STAYTON, PATRICK S. | reporter.nih.gov |
| Leveraging Variant-perturbed Gene Regulation to Support Precision Medicine in COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,361,465 | March 15, 2022 | February 28, 2027 | GLASS, KIMBERLY RENEE | reporter.nih.gov |
| Epigenome-wide variations and socio-environmental exposures in African American asthmatic children | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,355,328 | September 24, 2021 | June 30, 2026 | MERSHA, TESFAYE B. | reporter.nih.gov |
| Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,354,566 | September 1, 2021 | July 31, 2027 | KIM, JIWON | reporter.nih.gov |
| Maximizing Efficacy of Goal-Directed Sedation to Reduce Neurological Dysfunction in Mechanically Ventilated Infants and Children Study (mini-MENDS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,352,922 | September 15, 2021 | July 31, 2025 | SMITH, HEIDI A B | reporter.nih.gov |
| Developing Inhibitors of Seasonal and Pandemic Influenza Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,352,410 | August 18, 2025 | July 31, 2029 | PLEMPER, RICHARD K. | reporter.nih.gov |
| Viral respiratory infections in a tracheostomy cohort: Microbiome-host interplay | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,346,417 | September 21, 2022 | July 31, 2027 | MANSBACH, JONATHAN M | reporter.nih.gov |
| Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,344,916 | July 1, 2015 | April 30, 2026 | HUANG, LAURENCE | reporter.nih.gov |
| Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatment | NIH | National Cancer Institute | 2023 to 2025 | $3,343,401 | September 19, 2023 | August 31, 2028 | POTOSKY, ARNOLD L | reporter.nih.gov |
| Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,343,171 | January 9, 2019 | December 31, 2024 | IBRAHIM, ASHRAF S. | reporter.nih.gov |
| Multilevel Interventions to Increase Adherence to Lung Cancer Screening | NIH | National Cancer Institute | 2021 to 2025 | $3,340,674 | July 15, 2021 | June 30, 2027 | WERNLI, KAREN J | reporter.nih.gov |
| Regulation of Progenitor Cell Plasticity in Lung Development and Disease-Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,331,553 | July 1, 2023 | June 30, 2030 | CARDOSO, WELLINGTON V. | reporter.nih.gov |
| Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,331,422 | August 24, 2021 | April 30, 2027 | CAI, QIUYIN | reporter.nih.gov |
| 1/2 – Pediatric Prehospital Airway Resuscitation Trial | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,328,856 | September 1, 2023 | July 31, 2029 | WANG, HENRY E. | reporter.nih.gov |
| Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,325,603 | September 24, 2020 | August 31, 2025 | REZNIK, MARINA | reporter.nih.gov |
| A Phase III Randomized Controlled Trial of Azithromycin for RSV-induced Respiratory Failure in Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,324,945 | August 1, 2021 | July 31, 2027 | KONG, MICHELE | reporter.nih.gov |
| M. tuberculosis exosome detection for pediatric TB diagnosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,323,600 | June 1, 2025 | May 31, 2027 | LACOURSE, SYLVIA | reporter.nih.gov |
| Sleep Apnea Endophenotypes: One Size Does Not Fit All | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,318,435 | May 15, 2021 | April 30, 2027 | MALHOTRA, ATUL | reporter.nih.gov |
| Immunobiology of the normal and injured lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,312,758 | January 1, 2022 | December 31, 2028 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,307,657 | December 7, 2017 | June 30, 2027 | DE JESUS PEREZ, VINICIO A | reporter.nih.gov |
| Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal | NIH | National Cancer Institute | 2021 to 2024 | $3,305,824 | August 16, 2014 | March 31, 2025 | TAMKUS, DEIMANTE | reporter.nih.gov |
| The uptake and real-world effectiveness of emerging respiratory syncytial virus maternal vaccines and monoclonal antibodies on short- and long-term respiratory morbidities | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,304,164 | August 11, 2025 | July 31, 2029 | WU, PINGSHENG | reporter.nih.gov |
| A community-based trial of a voluntary smoke-free home intervention in permanent supportive housing for formerly homeless adults | NIH | National Cancer Institute | 2021 to 2025 | $3,303,677 | March 3, 2021 | February 28, 2026 | VIJAYARAGHAVAN, MAYA | reporter.nih.gov |
| Genomics of Pulmonary Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,302,250 | April 1, 2018 | March 31, 2025 | ALDRED, MICHEALA A | reporter.nih.gov |
| Lesion-centric optimization of multidrug therapies for tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,301,434 | January 15, 2020 | December 31, 2025 | ALDRIDGE, BREE BEARDSLEY | reporter.nih.gov |
| Transcriptional networks governing A. fumigatus virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,301,255 | September 22, 2021 | August 31, 2026 | FILLER, SCOTT G | reporter.nih.gov |
| The role of Chlamydia pneumoniae infection in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $3,300,943 | September 30, 2021 | June 30, 2027 | CROTHER, TIMOTHY ROBERT | reporter.nih.gov |
| The B7x pathways in the tumor microenvironment | NIH | National Cancer Institute | 2021 to 2025 | $3,299,614 | July 1, 2014 | November 30, 2026 | ZANG, XINGXING | reporter.nih.gov |
| Novel metabolomic contrast probes for human lung cancer characterization | NIH | National Cancer Institute | 2022 to 2025 | $3,297,251 | September 1, 2022 | August 31, 2027 | FARRAR, CHRISTIAN T | reporter.nih.gov |
| Pathogenesis of lung injury mediated by lung-restricted antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,293,690 | April 1, 2019 | March 31, 2027 | BHARAT, ANKIT | reporter.nih.gov |
| Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis | NIH | National Cancer Institute | 2021 to 2025 | $3,292,953 | July 1, 2021 | June 30, 2026 | RUIZ, JOHN M | reporter.nih.gov |
| Expanding population-level interventions to help more low-income smokers quit | NIH | National Cancer Institute | 2021 to 2023 | $3,284,616 | July 23, 2019 | June 30, 2024 | KREUTER, MATTHEW W. | reporter.nih.gov |
| Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,280,008 | July 1, 2020 | May 31, 2025 | FANTRY, LORI E | reporter.nih.gov |
| Type I IFN signaling during lung development in Down Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,274,532 | September 17, 2021 | June 30, 2027 | DANOPOULOS, SOULA ATHANASIA | reporter.nih.gov |
| The impact of central sleep apnea in patients receiving medications for opioid use disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,271,652 | September 30, 2023 | August 31, 2027 | PATEL, SANJAY R | reporter.nih.gov |
| Broad-spectrum therapeutics against SARS-CoV-2 3CL protease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,268,877 | August 19, 2021 | July 31, 2026 | SCHINAZI, RAYMOND FELIX | reporter.nih.gov |
| Aspiration in Acute Respiratory Failure Survivors | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,262,196 | August 23, 2021 | May 31, 2027 | MOSS, MARC | reporter.nih.gov |
| Identifying mechanisms and reversibility of eosinophil-induced airway hyperinnervation in asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,251,305 | February 1, 2021 | January 31, 2027 | DRAKE, MATTHEW G. | reporter.nih.gov |
| A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $3,249,318 | September 15, 2020 | April 30, 2025 | PLATAKI, MARIA | reporter.nih.gov |
| Video DOT and Economic Incentives to promote adherence to LTBI therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,246,780 | July 8, 2021 | June 30, 2027 | SHAH, MAUNANK | reporter.nih.gov |
| Evolution of T cell immunity in blood and tissues over childhood | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,243,813 | March 16, 2022 | February 28, 2027 | FARBER, DONNA L. | reporter.nih.gov |
| Metabolomics of obstructive sleep apnea | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,241,047 | July 1, 2020 | June 30, 2025 | WELJIE, AALIM M | reporter.nih.gov |
| Type 2 Inflammation and Remodeling Elicited Through an LTE4/OXGR1-dependent pathway | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,239,756 | February 1, 2018 | December 31, 2028 | BARRETT, NORA AMANDA | reporter.nih.gov |
| Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,237,702 | January 1, 2021 | December 31, 2026 | HOUPT, ERIC R | reporter.nih.gov |
| PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,235,332 | April 1, 2023 | March 31, 2028 | CATTAMANCHI, ADITHYA | reporter.nih.gov |
| 2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,234,679 | September 15, 2021 | November 30, 2026 | CHAKRABORTY, HRISHIKESH | reporter.nih.gov |
| Biological and lifestyle factors contributing to Tau in women at risk for Alzheimer's disease. | NIH | National Institute on Aging | 2023 to 2025 | $3,234,619 | September 15, 2023 | May 31, 2028 | BANKS, SARAH | reporter.nih.gov |
| Unraveling respiratory rhythm generation in medullary and supramedullary networks | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,231,145 | January 1, 2015 | February 29, 2028 | RAMIREZ, JAN M. | reporter.nih.gov |
| New Jersey ECHO | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $3,229,703 | September 1, 2023 | May 31, 2025 | BARRETT, EMILY S | reporter.nih.gov |
| 3-Dimensional genomic architecture in innate lymphoid cells and allergic inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,226,380 | June 20, 2022 | May 31, 2027 | HENAO-MEJIA, JORGE | reporter.nih.gov |
| Detecting and locating cancer for patients with CT-detected lung nodules | NIH | National Cancer Institute | 2022 to 2025 | $3,224,369 | September 14, 2022 | August 31, 2027 | ZHOU, XIANGHONG JASMINE | reporter.nih.gov |
| Pulmonary pathophysiology sub-phenotypes of pneumonia | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,223,607 | February 1, 2022 | January 31, 2027 | MIZGERD, JOSEPH P | reporter.nih.gov |
| Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,222,498 | September 21, 2016 | May 31, 2030 | CAMARGO, CARLOS ARTURO | reporter.nih.gov |
| Role of mucin in lung homeostasis and pathophysiology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,219,550 | August 1, 2009 | April 30, 2027 | EVANS, CHRISTOPHER M | reporter.nih.gov |
| Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,217,584 | April 2, 2020 | March 31, 2026 | SUN, VIRGINIA CHIH-YI | reporter.nih.gov |
| Uncovering associations of variant infection with COVID-19 disease severity in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $3,214,599 | January 1, 2021 | June 30, 2023 | CHIU, CHARLES YEN | reporter.nih.gov |
| Mycobacterium avium complex pulmonary infection: immunologic and transcriptomic signatures of disease and treatment response | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,209,026 | August 20, 2024 | July 31, 2028 | WINTHROP, KEVIN LORING | reporter.nih.gov |
| Variant Hemoglobin and Cardiorespiratory Regulation in Humans | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,208,613 | January 19, 2018 | November 30, 2024 | JOYNER, MICHAEL J | reporter.nih.gov |
| Improving Participation in Pulmonary Rehabilitation through Peer-Support and Storytelling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,200,137 | September 1, 2022 | August 31, 2027 | LINDENAUER, PETER KYLE | reporter.nih.gov |
| The state of energy in the right ventricle of patients with pulmonary arterial hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,198,508 | January 15, 2022 | December 31, 2026 | KHERADVAR, ARASH | reporter.nih.gov |
| Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,194,826 | January 1, 2025 | December 31, 2026 | SEGAL, LEOPOLDO NICOLAS | reporter.nih.gov |
| Dual Targeting of Mtb Resistance Mechanisms | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,194,513 | September 22, 2020 | August 31, 2025 | GRUNDNER, CHRISTOPH | reporter.nih.gov |
| Manufacturable Biomimetic Microfluidic Oxygenator for Safer, Simpler Treatment of Respiratory Failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,193,069 | September 17, 2024 | August 31, 2026 | BORENSTEIN, JEFFREY T. | reporter.nih.gov |
| Predicting response to non-PAP therapies in OSA using PSG-derived endotypes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,189,653 | September 15, 2022 | July 31, 2026 | WELLMAN, DAVID ANDREW | reporter.nih.gov |
| Developing a bioprinted ventilated lung alveolar platform for investigating microbial interactions and influenza response | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,182,827 | August 19, 2025 | July 31, 2029 | OH, JULIA | reporter.nih.gov |
| Elucidating the path to type I IFNs in TB infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,182,185 | April 1, 2021 | March 31, 2026 | BARCZAK, AMY K | reporter.nih.gov |
| Residential Greenness, Airway Microbiome,and Incident Childhood Asthma | NIH | National Institute of Environmental Health Sciences | 2025 | $3,181,155 | September 18, 2025 | September 17, 2029 | ZHU, ZHAOZHONG | reporter.nih.gov |
| Progenitors, Mechanisms of Differentiation, and Functions of Lung M Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,180,672 | August 1, 2022 | July 31, 2026 | RAJAGOPAL, JAYARAJ | reporter.nih.gov |
| In vivo endobronchial OCT for IPF diagnosis and therapy response assessment | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,179,658 | June 1, 2020 | May 31, 2026 | HARIRI, LIDA P | reporter.nih.gov |
| Identifying Protein-Protein Network Interactions between COPD Susceptibility Genes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,177,138 | January 1, 2021 | December 31, 2025 | SILVERMAN, EDWIN K | reporter.nih.gov |
| Biomarker Signatures of TB Infection in Young Children With and Without HIV | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,173,148 | April 28, 2023 | March 31, 2028 | SALGAME, PADMINI | reporter.nih.gov |
| Targeted Gene Delivery Systems Treating Lung Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,172,072 | June 15, 2022 | May 31, 2026 | TIRRELL, MATTHEW | reporter.nih.gov |
| Reducing lung cancer by decoding the link between neighborhood exposure and biological responses (RECODE) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,171,260 | May 6, 2021 | January 31, 2027 | KIM, SAGE J. | reporter.nih.gov |
| Development and optimization of a peptide inhibitor of influenza virus splicing for broad-spectrum antiviral therapy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,170,096 | August 1, 2025 | July 31, 2029 | TENOEVER, BENJAMIN R. | reporter.nih.gov |
| The effect of a housing mobility program on environmental exposures and asthma morbidity | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,169,561 | March 1, 2016 | June 30, 2027 | POLLACK, CRAIG EVAN | reporter.nih.gov |
| 1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,169,398 | September 15, 2021 | May 31, 2026 | ROMER, LEWIS H | reporter.nih.gov |
| Novel Biased Beta2-AR Ligands as Asthma Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,166,566 | March 15, 2021 | February 28, 2027 | WALKER, JULIA K L | reporter.nih.gov |
| Development of peptide nucleic acid antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,164,488 | February 10, 2021 | January 31, 2025 | ARYA, DEV PRIYA | reporter.nih.gov |
| Allergen-induced extracellular DNA in type 2 immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,163,994 | September 21, 2022 | July 31, 2027 | KITA, HIROHITO | reporter.nih.gov |
| Role of Ezrin in Macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,162,244 | July 1, 2021 | June 30, 2027 | BRUSCIA, EMANUELA MARINA | reporter.nih.gov |
| Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,159,973 | September 16, 2021 | August 31, 2026 | WU, JIA | reporter.nih.gov |
| Immune Development Across the Life Course: Integrating Exposures and Multi-Omics in the Boston Birth Cohort | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $3,158,931 | September 15, 2022 | June 30, 2027 | WANG, XIAOBIN | reporter.nih.gov |
| Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity | NIH | National Cancer Institute | 2023 to 2025 | $3,154,814 | September 19, 2023 | August 31, 2028 | BROWN, BRIAN D | reporter.nih.gov |
| Immunotherapy via engineered therapeutic programs in tumors using RNA | NIH | National Cancer Institute | 2021 to 2025 | $3,154,064 | September 20, 2021 | August 31, 2027 | WEISS, RON | reporter.nih.gov |
| Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,154,051 | September 1, 2022 | June 30, 2026 | NICHOLS, WILLIAM C | reporter.nih.gov |
| Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,153,883 | September 24, 2018 | October 31, 2028 | HEYSELL, SCOTT K | reporter.nih.gov |
| The Efficacy of CAMP Air, a Web-based Asthma Intervention, Among Urban Adolescents with Uncontrolled Asthma | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,150,671 | July 7, 2021 | June 30, 2027 | BRUZZESE, JEAN-MARIE | reporter.nih.gov |
| Gonadal hormones as mediators of sex and gender influences in asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,148,325 | July 10, 2021 | June 30, 2026 | SILVEYRA, PATRICIA | reporter.nih.gov |
| Macrophage senescence as a driver of granuloma failure and progression to necrosis in TB and TB/HIV | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,145,850 | September 19, 2025 | August 31, 2029 | BISHAI, WILLIAM RAMSES | reporter.nih.gov |
| Precision Approaches to Reduce Asthma Disparities with Electronic Health Record Data | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,142,554 | September 1, 2022 | May 31, 2027 | WEISSMAN, GARY | reporter.nih.gov |
| Relationship of fungal translocation, inflammation, and pulmonary function in HIV | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,142,352 | July 10, 2022 | May 31, 2027 | METHE, BARBARA | reporter.nih.gov |
| Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,139,781 | May 6, 2020 | April 30, 2026 | BRYSON, BRYAN DAVID | reporter.nih.gov |
| Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,136,573 | July 13, 2021 | June 30, 2025 | AUBE, JEFFREY | reporter.nih.gov |
| Regulation of Motile Cilia Assembly in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,135,349 | August 17, 2015 | March 31, 2029 | BRODY, STEVEN | reporter.nih.gov |
| Molecular pathogenesis of pulmonary arterial hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,134,947 | May 1, 2021 | January 31, 2026 | HATA, AKIKO | reporter.nih.gov |
| Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patient | NIH | National Cancer Institute | 2021 to 2025 | $3,134,857 | July 13, 2021 | June 30, 2027 | POGHOSYAN, HERMINE | reporter.nih.gov |
| Predicting the Need for Surgery in Pediatric Subglottic Stenosis using Airway Elastography Derived from Endoscopic OCT and Intraluminal Pressure Measurement | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,125,423 | September 1, 2020 | July 31, 2025 | OLDENBURG, AMY L | reporter.nih.gov |
| Mechanism for Programming of Offspring Adiposity by Maternal PM2.5 Exposure | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,124,436 | April 9, 2021 | January 31, 2026 | YING, ZHEKANG | reporter.nih.gov |
| The ALOHA trial: Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,123,405 | September 20, 2021 | August 31, 2027 | MA, JUN | reporter.nih.gov |
| Mechanisms of Enhanced Neutralizing Antibody Responses to Rhinovirus C | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,122,828 | March 20, 2020 | February 28, 2026 | BOCHKOV, YURY A | reporter.nih.gov |
| Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,121,383 | August 15, 2022 | July 31, 2026 | YANIK, GREGORY A | reporter.nih.gov |
| Optimizing Individualized and Adaptive mHealth Interventions via Control Systems Engineering Methods | NIH | National Cancer Institute | 2021 to 2024 | $3,121,021 | July 14, 2020 | June 30, 2026 | HEKLER, ERIC | reporter.nih.gov |
| Non-coding RNA structure change in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,120,996 | January 1, 2012 | August 31, 2027 | LAEDERACH, ALAIN T | reporter.nih.gov |
| The Effect of Ansa Cervicalis Neurostimulation on Airway Patency in Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,120,041 | January 15, 2022 | November 30, 2026 | KENT, DAVID T. | reporter.nih.gov |
| Penetrating the “Black box”: Prediction of early Bronchiolitis obliterans in Pediatric Hematopoietic Stem Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,117,523 | July 15, 2021 | April 30, 2027 | MYERS, KASIANI | reporter.nih.gov |
| Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,116,857 | May 1, 2016 | October 31, 2026 | AYALA, ALFRED | reporter.nih.gov |
| Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,116,400 | September 17, 2021 | August 31, 2027 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,114,564 | January 20, 2022 | December 31, 2026 | CHIRINOS MEDINA, JULIO ALONSO | reporter.nih.gov |
| Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,113,004 | August 8, 2022 | July 31, 2027 | PHELPS, MITCH A | reporter.nih.gov |
| Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,102,338 | September 18, 2020 | August 31, 2025 | HASELTON, FREDERICK R | reporter.nih.gov |
| Childhood Allergy and the NeOnatal Environment in St Louis (CANOE-STL) and the Impact of Wheezing Illnesses on Neurocognitive Development of Preschool Children | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $3,099,038 | September 1, 2023 | May 31, 2025 | RIVERA-SPOLJARIC, KATHERINE | reporter.nih.gov |
| Mechanisms of newborn pulmonary hypertension caused by chronic intrauterine hypoxia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,098,160 | January 1, 2022 | November 30, 2026 | BLOOD, ARLIN B | reporter.nih.gov |
| FEND-TB | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,089,360 | September 10, 2025 | August 31, 2030 | ELLNER, JERROLD J. | reporter.nih.gov |
| 2-HOBA for Treatment of Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,088,886 | September 1, 2021 | August 31, 2026 | RATHMACHER, JOHN A | reporter.nih.gov |
| Vascular Targeting of Nanocarriers for RNA | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,088,329 | February 5, 2021 | January 31, 2026 | MUZYKANTOV, VLADIMIR R | reporter.nih.gov |
| Pathogenic monocyte response to chronic lung inflammation in cystic fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,086,283 | January 1, 2022 | November 30, 2026 | BRUSCIA, EMANUELA MARINA | reporter.nih.gov |
| An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,085,449 | September 1, 2014 | April 30, 2027 | CHAN, STEPHEN Y | reporter.nih.gov |
| Integrative Genomics of Acute Asthma Control | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,084,719 | August 6, 2014 | January 31, 2025 | RABY, BENJAMIN ALEXANDER | reporter.nih.gov |
| Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,082,735 | February 1, 2021 | July 31, 2026 | CHOPRA, ASHOK K | reporter.nih.gov |
| Discovery of Gene-by-Air Pollution Interactions in Respiratory Disease using Genetically Diverse Mice with Validation in Humans | NIH | National Institute of Environmental Health Sciences | 2025 | $3,082,011 | September 19, 2025 | September 18, 2029 | KELADA, SAMIR | reporter.nih.gov |
| Novel Strategies for Antibiotic Combinations to Combat Gram-negative Superbugs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,081,358 | December 20, 2019 | November 30, 2025 | TSUJI, BRIAN | reporter.nih.gov |
| TCR-dependent and epigenetic mechanisms guiding influenza-specific CD4+ T cell responses in the lung | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,078,308 | August 1, 2025 | July 31, 2029 | HALE, JEFFREY SCOTT | reporter.nih.gov |
| Airway Innate Immune Responses to Coccidioides Infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,075,549 | July 28, 2025 | June 30, 2029 | CHEN, YIN | reporter.nih.gov |
| Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay | NIH | National Cancer Institute | 2022 to 2025 | $3,075,394 | September 1, 2022 | August 31, 2027 | WU, YUN | reporter.nih.gov |
| Multilevel Determinants of Circadian Factors and Sleep Disruption: Implications for Cardiometabolic Health Among African-Americans | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,072,346 | September 1, 2022 | July 31, 2027 | JOHNSON, DAYNA | reporter.nih.gov |
| Animal Models for Studying the Genetics of Complex Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,068,389 | September 30, 1992 | December 31, 2026 | MAEDA, NOBUYO | reporter.nih.gov |
| Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | NIH | National Cancer Institute | 2021 to 2025 | $3,067,733 | April 1, 2021 | March 31, 2026 | KENDZOR, DARLA ELIZABETH | reporter.nih.gov |
| Novel delivery platform and antigen design for an effective COVID-19 vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,066,236 | August 11, 2020 | July 31, 2027 | MITTAL, SURESH K | reporter.nih.gov |
| Donor nonclassical monocytes mediate primary graft dysfunction and remote organ injury following lung transplant surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,065,003 | January 1, 2019 | December 31, 2028 | BHARAT, ANKIT | reporter.nih.gov |
| Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,064,576 | September 25, 2020 | August 31, 2025 | HEISE, MARK T | reporter.nih.gov |
| Personalized Motion Management for Truly 4D Lung Radiotherapy | NIH | National Cancer Institute | 2021 to 2025 | $3,062,893 | July 16, 2021 | June 30, 2027 | SAWANT, AMIT | reporter.nih.gov |
| CD28-KITv CAR T cells with PD-1 dominant negative receptor | NIH | National Cancer Institute | 2024 to 2025 | $3,061,861 | March 1, 2024 | February 28, 2026 | ADUSUMILLI, PRASAD S. | reporter.nih.gov |
| Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,061,547 | January 1, 2017 | December 31, 2026 | PHILIPS, JENNIFER A | reporter.nih.gov |
| Pathogenic Exosomes in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,057,675 | April 1, 2023 | March 31, 2030 | BLALOCK, J EDWIN | reporter.nih.gov |
| Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,053,206 | January 10, 2020 | December 31, 2025 | NAGAJYOTHI, JYOTHI FALGUNI | reporter.nih.gov |
| Clinical and Mechanistic Understanding of Right Ventricular Steatosis in Pulmonary Arterial Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,053,152 | August 25, 2022 | July 31, 2027 | BRITTAIN, EVAN L | reporter.nih.gov |
| The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,052,433 | June 1, 2020 | April 30, 2026 | PRESS, VALERIE G | reporter.nih.gov |
| Leveraging population-based human data to uncover mechanisms connecting Alzheimer's disease and common infections and facilitate vaccines repurposing for AD prevention | NIH | National Institute on Aging | 2021 to 2025 | $3,052,023 | September 30, 2021 | June 30, 2027 | OUKRAINTSEVA, SVETLANA V. | reporter.nih.gov |
| Reducing Asthma Attacks in Disadvantaged School Children with Asthma | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,049,831 | September 10, 2020 | August 31, 2027 | SZEFLER, STANLEY J. | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Leidos Biomedical Research, Inc. | Frederick, MD | 2 | $2.96 billion | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 221 | $342 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 232 | $323.1 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 34 | $297.2 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 187 | $247.2 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 195 | $243.7 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 217 | $233.4 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 123 | $228.6 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 156 | $213.7 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 170 | $201.7 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 145 | $201.4 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 148 | $175.7 million | 0 | $0 |
| Washington University | Saint Louis, MO | 137 | $174.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 125 | $171.1 million | 0 | $0 |
| Duke University | Durham, NC | 128 | $151.6 million | 0 | $0 |
| University of Washington | Seattle, WA | 124 | $144.9 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 60 | $142.8 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 86 | $142.5 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 90 | $142.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 114 | $141.5 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 95 | $141.1 million | 0 | $0 |
| Ohio State University | Columbus, OH | 98 | $136.9 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 41 | $136.6 million | 0 | $0 |
| Emory University | Atlanta, GA | 129 | $135.6 million | 0 | $0 |
| Yale University | New Haven, CT | 114 | $132 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 81 | $130.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 78 | $130.4 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 111 | $129 million | 0 | $0 |
| National Jewish Health | Denver, CO | 68 | $120.5 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 59 | $118 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 97 | $117.5 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 91 | $116.3 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 67 | $108.1 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 33 | $106.2 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 64 | $100 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 74 | $99.7 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 80 | $99.7 million | 0 | $0 |
| University of Florida | Gainesville, FL | 81 | $91.7 million | 0 | $0 |
| Westat, Inc. | Bethesda, MD | 3 | $89.9 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 83 | $89.1 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 12 | $84.8 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 75 | $84.3 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 66 | $83.8 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 53 | $83.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 60 | $83.1 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 64 | $79.5 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 61 | $75.4 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 61 | $72 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 77 | $70.9 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 57 | $69 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 21 | $67.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 50 | $67.7 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 49 | $65.2 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 39 | $63.5 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 55 | $59.6 million | 0 | $0 |
| University of Chicago | Chicago, IL | 56 | $59.1 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 31 | $58.9 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 38 | $57.3 million | 0 | $0 |
| University of Rochester | Rochester, NY | 45 | $56.3 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 52 | $53 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 39 | $50.5 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 20 | $45.6 million | 0 | $0 |
| Louisiana State University | Baton Rouge, LA | 17 | $42.6 million | 0 | $0 |
| University of California at Davis | Davis, CA | 44 | $41.7 million | 0 | $0 |
| University of Louisville | Louisville, KY | 24 | $39.3 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 52 | $38.7 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 17 | $38.6 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 31 | $37.2 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 15 | $35.7 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 29 | $35.6 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 25 | $35.5 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 35 | $35.3 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 22 | $34.7 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 35 | $34.5 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 24 | $34.3 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 30 | $33 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 31 | $33 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 25 | $33 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 38 | $32.9 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 31 | $29.3 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 22 | $29.3 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 18 | $28.7 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 24 | $28.2 million | 0 | $0 |
| Rho Federal Systems Division, Inc. | Durham, NC | 1 | $28.2 million | 0 | $0 |
| Hackensack University Medical Center | Hackensack, NJ | 12 | $27.6 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 27 | $27.4 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 8 | $27.2 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 22 | $24.9 million | 0 | $0 |
| Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center | Torrance, CA | 15 | $24.5 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 30 | $24.1 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 23 | $23.7 million | 0 | $0 |
| Texas Biomedical Research Institute | San Antonio, TX | 18 | $23.1 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 17 | $22.7 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 29 | $22.6 million | 0 | $0 |
| La Jolla Institute for Immunology | La Jolla, CA | 10 | $22.3 million | 0 | $0 |
| SUNY Downstate Medical Center | Brooklyn, NY | 4 | $22.2 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 20 | $21.5 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 21 | $21.3 million | 0 | $0 |
| Marshall University Research Corporation | Huntington, WV | 3 | $21.1 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 17 | $21.1 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3,725 | $2,679,461,346 | 0 | $0 |
| 2024 | 3,856 | $2,777,494,774 | 0 | $0 |
| 2023 | 3,862 | $3,014,176,791 | 0 | $0 |
| 2022 | 3,740 | $2,776,123,968 | 0 | $0 |
| 2021 | 3,704 | $2,632,302,557 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.